Aton Ra Partners Vertex Pharmaceuticals Inc Transaction History

Aton Ra Partners

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$187.49 - $221.1 $2.5 Million - $2.94 Million	-13,319 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $364,148 - $424,464	1,759 Added 15.22%	13,319 $2.86 Million
Q4 2020 Feb 19, 2021	BUY	$207.01 - $276.09 $2.39 Million - $3.19 Million	11,560 New	11,560 $2.73 Million

1,708

226M

1.2M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

Stay updated on Aton Ra Partners with notifications on news.